China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SZSE:000999

Watchlist Manager
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Logo
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SZSE:000999
Watchlist
Price: 45.69 CNY -3.75% Market Closed
Market Cap: 58.3B CNY
Have any thoughts about
China Resources Sanjiu Medical & Pharmaceutical Co Ltd?
Write Note

Net Margin
China Resources Sanjiu Medical & Pharmaceutical Co Ltd

13.1%
Current
13%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
13.1%
=
Net Income
3.4B
/
Revenue
25.7B

Net Margin Across Competitors

Country CN
Market Cap 58.7B CNY
Net Margin
13%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 710.5B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.3T DKK
Net Margin
35%
Country US
Market Cap 373.5B USD
Net Margin
17%
Country US
Market Cap 251.1B USD
Net Margin
19%
Country CH
Market Cap 202.7B CHF
Net Margin
20%
Country CH
Market Cap 183.3B CHF
Net Margin
35%
Country UK
Market Cap 162.4B GBP
Net Margin
13%
Country IE
Market Cap 146B USD
Net Margin
-126%
No Stocks Found

China Resources Sanjiu Medical & Pharmaceutical Co Ltd
Glance View

Market Cap
58.7B CNY
Industry
Pharmaceuticals

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., a leading player in the healthcare sector, has carved a distinguished path through its commitment to innovation and quality. Established in 1992, the company has grown into a comprehensive healthcare provider with a diverse product portfolio that includes traditional Chinese medicine, over-the-counter drugs, and prescription medications. Leveraging its strong distribution network and extensive research and development capabilities, Sanjiu has positioned itself as a trusted brand among consumers and healthcare professionals alike. As the Chinese healthcare market continues to expand, fueled by a growing middle class and increasing health awareness, Sanjiu is well-poised to capitalize on these trends, driving both revenue growth and market share expansion. An investor looking into China Resources Sanjiu will find a company that not only maintains a robust financial foundation but also demonstrates an unwavering focus on sustainable practices and innovation. The company’s strategic partnerships and investments in modern technology, including digital health and telemedicine, further amplify its competitive edge. With a proactive approach to meeting evolving healthcare demands and an eye on regulatory developments, Sanjiu is not just a health-focused enterprise but a forward-thinking entity that embraces change in a dynamic industry. By combining traditional wisdom with modern methodologies, China Resources Sanjiu stands at the intersection of heritage and innovation, offering promising avenues for long-term growth and investor confidence.

Intrinsic Value
57.27 CNY
Undervaluation 20%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
13.1%
=
Net Income
3.4B
/
Revenue
25.7B
What is the Net Margin of China Resources Sanjiu Medical & Pharmaceutical Co Ltd?

Based on China Resources Sanjiu Medical & Pharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of 13.1%.